162 related articles for article (PubMed ID: 35723873)
41. [Monoclonal gammopathy of clinical importance].
Tjønnfjord GE; Schjesvold FH; Gulbrandsen N; Kvam AK
Tidsskr Nor Laegeforen; 2021 Sep; 141(2021-13):. PubMed ID: 34596996
[TBL] [Abstract][Full Text] [Related]
42. The promise and harms of screening for plasma cell dyscrasias.
Mohyuddin GR; Chakraborty R; Cliff ERS
Br J Haematol; 2023 Mar; 200(6):704-707. PubMed ID: 36626939
[TBL] [Abstract][Full Text] [Related]
43. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
44. [Long-term follow-up of monoclonal gammopathies of undetermined significance (MGUS)].
Goldschmidt H; Nitschmann S
Internist (Berl); 2018 Jun; 59(6):639-640. PubMed ID: 29696302
[No Abstract] [Full Text] [Related]
45. Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathy.
Al Hariri M; Munder M; Lisch W; Schuster AK; Fehr EM; Jacobi B; Desuki A; Kreft A; Gericke A; Pfeiffer N; Wasielica-Poslednik J
PLoS One; 2022; 17(10):e0276048. PubMed ID: 36315502
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of monoclonal gammopathy in Morocco - A hospital-based study.
Ouzzif Z; Doghmi K; Messaoudi N; Bouhsain S; El Machtani S; Biaz A; Rachid A; Dami A; Bezza A; El Maataoui A
Cancer Rep (Hoboken); 2023 May; 6(5):e1814. PubMed ID: 36999311
[TBL] [Abstract][Full Text] [Related]
47. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
48. A bone paradigm challenging the standard model of myeloma oncogenesis.
Capp JP; Bataille R
Crit Rev Oncol Hematol; 2022 Apr; 172():103640. PubMed ID: 35183697
[TBL] [Abstract][Full Text] [Related]
49. Smoldering Myeloma Presenting with Renal Histopathology of Monoclonal Gammopathy of Renal Significance: Adding to the Complexity.
Kousios A; Duncan N; Charif R; Roufosse C
J Am Soc Nephrol; 2018 Dec; 29(12):2901. PubMed ID: 30377233
[No Abstract] [Full Text] [Related]
50. [Monoclonal gammopathy of undetermined significance with recurrent skin bleeding: a case report].
Xiao YY; Zhang Y; Cao C; Luo Y; Lou SF
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1050. PubMed ID: 36709114
[No Abstract] [Full Text] [Related]
51. Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria.
Belouni R; Allam I; Cherguelaine K; Berkani L; Belaid B; Berkouk Y; Nekkal S; Saidani M; Belhani M; Ghaffor M; Djidjik R
Curr Res Transl Med; 2020 Apr; 68(2):67-70. PubMed ID: 31761679
[TBL] [Abstract][Full Text] [Related]
52. Thrombotic microangiopathy associated with monoclonal gammopathy.
Ravindran A; Go RS; Fervenza FC; Sethi S
Kidney Int; 2017 Mar; 91(3):691-698. PubMed ID: 27998645
[TBL] [Abstract][Full Text] [Related]
53. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.
Bida JP; Kyle RA; Therneau TM; Melton LJ; Plevak MF; Larson DR; Dispenzieri A; Katzmann JA; Rajkumar SV
Mayo Clin Proc; 2009 Aug; 84(8):685-93. PubMed ID: 19648385
[TBL] [Abstract][Full Text] [Related]
54. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
[TBL] [Abstract][Full Text] [Related]
55. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Haematologica; 2012 Jun; 97(6):854-8. PubMed ID: 22180421
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France.
Lecluse Y; Comby E; Mariotte D; Tual S; Le Mauff B; Lebailly P; Gauduchon P
Leuk Lymphoma; 2016 Jul; 57(7):1727-30. PubMed ID: 26689498
[No Abstract] [Full Text] [Related]
58. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
Kleinstern G; Larson DR; Allmer C; Norman AD; Muntifering G; Sinnwell J; Visram A; Rajkumar V; Dispenzieri A; Kyle RA; Slager SL; Kumar S; Vachon CM
Blood Cancer J; 2022 Apr; 12(4):67. PubMed ID: 35440099
[TBL] [Abstract][Full Text] [Related]
59. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.
Fujimura K; Sugiyama A; Akita T; Ohisa M; Nagashima S; Katayama K; Maeda R; Tanaka J
Int J Hematol; 2021 Apr; 113(4):576-585. PubMed ID: 33389658
[TBL] [Abstract][Full Text] [Related]
60. Screening for and diagnosis of monoclonal gammopathy.
Chong YP; Lim SM; Loh TP; Mollee P; Wijeratne N; Choy KW
J Clin Pathol; 2023 Nov; 76(11):727-733. PubMed ID: 37604683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
